{"product_id":"how-to-reduce-overuse-in-healthcare-isbn-9781119862727","title":"How to Reduce Overuse in Healthcare","description":"\u003cb\u003eHOW TO REDUCE OVERUSE IN HEALTHCARE\u003c\/b\u003e \u003cp\u003e\u003cb\u003eReduce low-value care with this practical guide\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eLow-value care harms patients, overburdens healthcare professionals, threatens healthcare systems and damages the climate. \u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003eis designed to provide practical guidance and tools for healthcare providers, their professional societies and policy makers developing programs to de-implement low-value or unnecessary care. This guide provides a five-step evidence and theory-based framework for developing and evaluating programs such as Choosing Wisely to reduce low-value care and improve patient outcomes. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003ereaders will also find: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eAn author team involved in the leading Choosing Wisely international network\u003c\/li\u003e \u003cli\u003eDetailed analysis of how to identify potential low-value care areas, select interventions and more\u003c\/li\u003e \u003cli\u003ePractical, real-world examples at the end of each chapter illustrating examples of overuse and de-implementation\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003edescribes the state of the art in de-implementation for healthcare professionals, healthcare administrators and policy makers looking to reduce low-value care in a more effective and evidence-based way. \u003c\/p\u003e\u003cp\u003ePreface x\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 Why Should We Reduce Medical Overuse? 1\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eKaren Born and Wendy Levinson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIt Started with Quality Improvement 1\u003c\/p\u003e \u003cp\u003eThen Came a Focus on Overuse 3\u003c\/p\u003e \u003cp\u003eOveruse as a Global Healthcare Quality Concern 5\u003c\/p\u003e \u003cp\u003eWhat Can Be Done to Address Overuse? 6\u003c\/p\u003e \u003cp\u003eChoosing Wisely 7\u003c\/p\u003e \u003cp\u003eWhat Can you Expect in the Following Chapters? 9\u003c\/p\u003e \u003cp\u003eReferences 10\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Why Does Overuse Exist? 13\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eTijn Kool, Simone van Dulmen, Andrea M. Patey, and Jeremy M. Grimshaw\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eA Multifactorial Challenge on Different Levels 13\u003c\/p\u003e \u003cp\u003eHealthcare Professional Factors 14\u003c\/p\u003e \u003cp\u003ePatient Factors 15\u003c\/p\u003e \u003cp\u003ePreference for Acquiring Something 16\u003c\/p\u003e \u003cp\u003eClinical Care Context Factors 16\u003c\/p\u003e \u003cp\u003eAbsence of an Open Culture 17\u003c\/p\u003e \u003cp\u003eAbsence of Clear Leadership 17\u003c\/p\u003e \u003cp\u003eHealthcare Organisation Factors 18\u003c\/p\u003e \u003cp\u003eInsufficient Time 18\u003c\/p\u003e \u003cp\u003eLack of Coordination Amongst Healthcare Providers 19\u003c\/p\u003e \u003cp\u003eHealthcare System Factors 19\u003c\/p\u003e \u003cp\u003ePayment System that Rewards Volume 19\u003c\/p\u003e \u003cp\u003eInfluence of the Pharmaceutical and Medical Device Industry 20\u003c\/p\u003e \u003cp\u003eHealthcare Insurance Policy 20\u003c\/p\u003e \u003cp\u003eKey Points 20\u003c\/p\u003e \u003cp\u003eReferences 21\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 Why Is It So Hard to Change Behaviour and How Can We Influence It? 23\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJill J. Francis, Sanne Peters, Andrea M. Patey, Nicola McCleary, Leti van Bodegom- Vos, and Harriet Hiscock\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe Challenge of Behaviour Change 24\u003c\/p\u003e \u003cp\u003eIs The Behaviour a Routine? 24\u003c\/p\u003e \u003cp\u003eIs The Behaviour Rewarding? 24\u003c\/p\u003e \u003cp\u003eDo Habits or Routines Play a Role in Sustaining the Behaviour? 26\u003c\/p\u003e \u003cp\u003eFour Crucial Questions to Address Before Working to Support Behaviour Change 28\u003c\/p\u003e \u003cp\u003eWhy Is It So Difficult to Change the Behaviour of Healthcare Professionals? 30\u003c\/p\u003e \u003cp\u003eDesigning Interventions to Change Behaviour 35\u003c\/p\u003e \u003cp\u003eSummary 36\u003c\/p\u003e \u003cp\u003eSources of Information for Supporting Practice Change Among Healthcare Professionals 36\u003c\/p\u003e \u003cp\u003eReferences 36\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4 How Can We Reduce Overuse: The Choosing Wisely De- Implementation Framework 41\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJeremy M. Grimshaw and Andrea M. Patey\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 41\u003c\/p\u003e \u003cp\u003eThe Choosing Wisely De- Implementation Framework 44\u003c\/p\u003e \u003cp\u003ePhase 0: Identification of Potential Areas of Low- Value Healthcare 44\u003c\/p\u003e \u003cp\u003ePhase 1: Identification of Local Prioritiesfor the Implementation of Recommendations 45\u003c\/p\u003e \u003cp\u003ePhase 2: Identification of Barriers and Enablers to Implementing Recommendations and Potential Interventions to Overcome These 46\u003c\/p\u003e \u003cp\u003ePhase 3: Evaluation of the Implementation 48\u003c\/p\u003e \u003cp\u003ePhase 4: Spread of Effective Implementation Programs 49\u003c\/p\u003e \u003cp\u003eKey Points 50\u003c\/p\u003e \u003cp\u003eReferences 51\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5 How Can You Engage Patients in De- Implementation Activities? 54\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eStuart G. Nicholls, Brian Johnston, Barbara Sklar, and Holly Etchegary\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhat Is Patient Engagement and Why is it Relevant to De- Implementation? 54\u003c\/p\u003e \u003cp\u003eMaking a Patient Engagement Plan 56\u003c\/p\u003e \u003cp\u003eThe Level of Engagement 57\u003c\/p\u003e \u003cp\u003eArea 1 – Patient Engagement in Agenda Setting and Prioritisation 61\u003c\/p\u003e \u003cp\u003eArea 2 – Patient Engagement in the Design and Conduct of De- Implementation Activities 64\u003c\/p\u003e \u003cp\u003eArea 3 – Patient Engagement in Spread 65\u003c\/p\u003e \u003cp\u003eImportant Considerations when Engaging Patients 66\u003c\/p\u003e \u003cp\u003eKey Points 68\u003c\/p\u003e \u003cp\u003eSources of Information 69\u003c\/p\u003e \u003cp\u003eGeneral Resources 69\u003c\/p\u003e \u003cp\u003ePlanning Tools 69\u003c\/p\u003e \u003cp\u003ePatient Engagement Methods 70\u003c\/p\u003e \u003cp\u003eEvaluation Tools 70\u003c\/p\u003e \u003cp\u003eReferences 70\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6 Identifying Potential Areas of Low- Value Healthcare- Phase 0 73\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eMoriah E. Ellen, Saritte M. Perlman, and Jeremy M. Grimshaw\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eHow to Identify Low- Value Care? 73\u003c\/p\u003e \u003cp\u003eResources to Identify Low- Value Care 75\u003c\/p\u003e \u003cp\u003eRecommendation Lists 76\u003c\/p\u003e \u003cp\u003eClinical Practice Guidelines 77\u003c\/p\u003e \u003cp\u003eHealth Technology Assessments 77\u003c\/p\u003e \u003cp\u003eEvidence Syntheses and Systematic Reviews 78\u003c\/p\u003e \u003cp\u003eFrom Identification to Measurement 78\u003c\/p\u003e \u003cp\u003eKey Points 84\u003c\/p\u003e \u003cp\u003eSources of Further Information 84\u003c\/p\u003e \u003cp\u003eReferences 84\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7 Measuring Low- Value Care and Choosing Your Local Priority (Phase 1) 88\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eCarole E. Aubert, Karen Born, Eve A. Kerr, Sacha Bhatia, and Eva W. Verkerk\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eChoosing Your Local Priority 89\u003c\/p\u003e \u003cp\u003eMeasuring Low- Value Care 89\u003c\/p\u003e \u003cp\u003eBaseline Measurements 90\u003c\/p\u003e \u003cp\u003eEstimating Improvement Potential 91\u003c\/p\u003e \u003cp\u003eEvaluating De- Implementation Effects 91\u003c\/p\u003e \u003cp\u003eMeasuring Unintended Consequences 94\u003c\/p\u003e \u003cp\u003eMeasurement Methods and Data Source 95\u003c\/p\u003e \u003cp\u003eSetting Specific, Measurable, Achievable, Relevant, and Time- Bound (SMART) Targets 98\u003c\/p\u003e \u003cp\u003eProviding Data and Feedback to Stakeholders 98\u003c\/p\u003e \u003cp\u003eKey Points 100\u003c\/p\u003e \u003cp\u003eReferences 100\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8 Identifying Target Behaviours and Potential Barriers to Change (Phase 2a) 103\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eAndrea M. Patey, Nicola McCleary, Justin Presseau, Tijn Kool, Simone van Dulmen, and Jeremy M. Grimshaw\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eThe Importance of Fully Understanding the Problem 104\u003c\/p\u003e \u003cp\u003eGetting Started 104\u003c\/p\u003e \u003cp\u003eIdentifying Who Needs to do What Differently 105\u003c\/p\u003e \u003cp\u003eUsing the Action, Actor, Context, Target, Time (Aactt) Framework 106\u003c\/p\u003e \u003cp\u003eIdentifying Drivers of Current Behaviour and Barriers and Enablers to Changing Behaviour 109\u003c\/p\u003e \u003cp\u003eCollecting Data 112\u003c\/p\u003e \u003cp\u003eInterviews 112\u003c\/p\u003e \u003cp\u003eFocus Groups 114\u003c\/p\u003e \u003cp\u003eSurveys 116\u003c\/p\u003e \u003cp\u003eAnalysing the Data 118\u003c\/p\u003e \u003cp\u003eNarrowing Down the Drivers or Barriers Identified 118\u003c\/p\u003e \u003cp\u003eKey Points 119\u003c\/p\u003e \u003cp\u003eUseful Resources 120\u003c\/p\u003e \u003cp\u003eReferences 120\u003c\/p\u003e \u003cp\u003eAppendix: Sample Interview Guide for Healthcare Providers Using the Tdf 122\u003c\/p\u003e \u003cp\u003eIntroduction Script 122\u003c\/p\u003e \u003cp\u003eBackground 123\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9 Selecting De-Implementation Strategies and Designing Interventions: Phase 2b 131\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eJustin Presseau, Nicola McCleary, Andrea M. Patey, Sheena McHugh, and Fabiana Lorencatto\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhat Do You Need To Do Before Selecting De- Implementation Strategies? 132\u003c\/p\u003e \u003cp\u003eTen General Principles to Consideras you Develop a de- Implementation Intervention 132\u003c\/p\u003e \u003cp\u003e1. There Are No Magic Bullets: Design Your De- Implementation Intervention to Address Specific Barriers and Enablers 132\u003c\/p\u003e \u003cp\u003e2. De- Implementation Interventions Are Often Also Implementation Interventions when Substituting One Practice with Another 133\u003c\/p\u003e \u003cp\u003e3. Routinised, Habitually Performed Care May Be Operating Semi- Automatically 134\u003c\/p\u003e \u003cp\u003e4. Follow the Evidence Wherever Possible when Designing Your De- Implementation Intervention 135\u003c\/p\u003e \u003cp\u003e5. Avoid the Tower of Babel: Leverage Existing Listsof Change Strategies and Use Them to Help Match Specific Strategies to Identified Barriers\/Enablers 136\u003c\/p\u003e \u003cp\u003e6. Avoid Conflating Intervention Content with Its Method of Delivery 139\u003c\/p\u003e \u003cp\u003e7. Decide on Tailoring and Adaptation 140\u003c\/p\u003e \u003cp\u003e8. Co- Development, User- Centred Design to Enhance Feasibility, Acceptability, and Implementability 140\u003c\/p\u003e \u003cp\u003e9. Prioritise Equity 141\u003c\/p\u003e \u003cp\u003e10. Describe How the Strategy Works by Developing a De- Implementation Logic Model of Change 142\u003c\/p\u003e \u003cp\u003eKey Points 143\u003c\/p\u003e \u003cp\u003eSources 144\u003c\/p\u003e \u003cp\u003eReferences 144\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10 Evaluating De- Implementation Interventions: Phase 3 149\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eBeatriz Goulao, Eva W. Verkerk, Kednapa Thavorn, Justin Presseau, and Monica Taljaard\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhy Should We Evaluate? 150\u003c\/p\u003e \u003cp\u003eOutcomes 150\u003c\/p\u003e \u003cp\u003eTypes of Evaluations 151\u003c\/p\u003e \u003cp\u003eRandomised Evaluations 152\u003c\/p\u003e \u003cp\u003eNon- Randomised Evaluations 154\u003c\/p\u003e \u003cp\u003eSelecting the Most Appropriate Evaluation Method 156\u003c\/p\u003e \u003cp\u003eHow and Why Does the Intervention Work? 158\u003c\/p\u003e \u003cp\u003eDoes the Intervention Offer Good Value for Money? 160\u003c\/p\u003e \u003cp\u003eKey Points 161\u003c\/p\u003e \u003cp\u003eReferences 162\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11 Preserving Results and Spreading Interventions: Phase 4 166\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eSimone van Dulmen, Daniëlle Kroon, and Tijn Kool\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eWhy Are Sustainability and Spread So Important? 166\u003c\/p\u003e \u003cp\u003eWhat Is Sustainability? 167\u003c\/p\u003e \u003cp\u003eFactors Influencing Sustained Change 168\u003c\/p\u003e \u003cp\u003eFactors Related to the Process 168\u003c\/p\u003e \u003cp\u003eFactors Related to Staff 170\u003c\/p\u003e \u003cp\u003eFactors Related to the Organisation 170\u003c\/p\u003e \u003cp\u003eHow Can You Facilitate Sustainability? 171\u003c\/p\u003e \u003cp\u003eAssessing Sustainability 172\u003c\/p\u003e \u003cp\u003eSustainability and Culture 173\u003c\/p\u003e \u003cp\u003eSpreading Successful De- Implementation Interventions 174\u003c\/p\u003e \u003cp\u003eScaling Strategy 175\u003c\/p\u003e \u003cp\u003eDe- Implementation Intervention 176\u003c\/p\u003e \u003cp\u003eAdopters or Adopting Organisation 177\u003c\/p\u003e \u003cp\u003eExternal Context 177\u003c\/p\u003e \u003cp\u003eKey Points 178\u003c\/p\u003e \u003cp\u003eReferences 178\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 12 Training the Next Generation of Healthcare Providers to Address Overuse and Avoid Low- Value Care 181\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eBrian M. Wong, Christopher Moriates, Lorette Stammen, and Karen Born\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 182\u003c\/p\u003e \u003cp\u003eHigh- Value Care Competencies 182\u003c\/p\u003e \u003cp\u003eTeaching Students and Trainees To Provide High- Value Care 183\u003c\/p\u003e \u003cp\u003eEducational Changes to the Formal Curriculum 183\u003c\/p\u003e \u003cp\u003eFaculty Role Modellingand Supportive Learning Environments 186\u003c\/p\u003e \u003cp\u003eAssessing High- Value Care Learning Outcomes 190\u003c\/p\u003e \u003cp\u003eEnablers of Educational Change 191\u003c\/p\u003e \u003cp\u003eAligning Continuing Professional Development and Quality Improvement 192\u003c\/p\u003e \u003cp\u003eKey Points 193\u003c\/p\u003e \u003cp\u003eSources 196\u003c\/p\u003e \u003cp\u003eReferences 196\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 13 Examples from Clinical Practice 199\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eSimone van Dulmen, Daniëlle Kroon, Tijn Kool, Kyle Kirkham, and Johanna Caro Mendivelso\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 199\u003c\/p\u003e \u003cp\u003eReferences 215\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 14 Starting Tomorrow 217\u003cbr\u003e \u003c\/b\u003e\u003ci\u003eTijn Kool, Andrea M. Patey, Jeremy M. Grimshaw, and Simone van Dulmen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 221\u003c\/p\u003e  \u003cp\u003e\u003cb\u003eTijn Kool, MD PhD, \u003c\/b\u003eis Full Professor Appropriate Care at the Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eAndrea M. Patey, PhD, \u003c\/b\u003eis Senior Research Associate in the Centre for Implementation Research in the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Canada. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eSimone van Dulmen, PhD, \u003c\/b\u003eis Senior Researcher in Appropriate and Sustainable Healthcare at the Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands. \u003c\/p\u003e\u003cp\u003e\u003cb\u003eJeremy M. Grimshaw, MBChB, PhD, \u003c\/b\u003eSenior Scientist in the Centre for Implementation Research in the Clinical Epidemiology Program, Ottawa Hospital Research Institute, Canada.   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eReduce low-value care with this practical guide\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eLow-value care harms patients, overburdens healthcare professionals, threatens healthcare systems and damages the climate. \u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003eis designed to provide practical guidance and tools for healthcare providers, their professional societies and policy makers developing programs to de-implement low-value or unnecessary care. This guide provides a five-step evidence and theory-based framework for developing and evaluating programs such as Choosing Wisely to reduce low-value care and improve patient outcomes. \u003c\/p\u003e\u003cp\u003e\u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003ereaders will also find: \u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eAn author team involved in the leading Choosing Wisely international network\u003c\/li\u003e \u003cli\u003eDetailed analysis of how to identify potential low-value care areas, select interventions and more\u003c\/li\u003e \u003cli\u003ePractical, real-world examples at the end of each chapter illustrating examples of overuse and de-implementation\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003ci\u003eHow to Reduce Overuse in Healthcare: a practical guide \u003c\/i\u003edescribes the state of the art in de-implementation for healthcare professionals, healthcare administrators and policy makers looking to reduce low-value care in a more effective and evidence-based way.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989382938853,"sku":"NP9781119862727","price":65.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119862727.jpg?v=1761783896","url":"https:\/\/k12savings.com\/products\/how-to-reduce-overuse-in-healthcare-isbn-9781119862727","provider":"K12savings","version":"1.0","type":"link"}